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Butirosin is an interesting 2-deoxystreptamine (DOS)-containing aminoglycoside antibiotic produced by non-actinomycete Bacilli. Recently we were successful in purification of 2-deoxy-,scy//0-inosose synthase from butirosin-producer Bacillus circulans as the key enzyme for the biosynthesis of DOS, in cloning of the responsible gene (btrC), and in its overexpression in Escherichia coli. The present study involved gene-walking approach, which allowed us to find a gene cluster around btrC. The function of each gene was further investigated by gene disruption, and the disruptants of btrB, btrC, btrD and btrM showed no antibiotic producing activity. Therefore, the gene cluster found so far was determined to be a part of the butirosin biosynthetic gene cluster. Functions of some ORFsare also discussed in terms ofbutirosin biosynthesis on the basis of database search.
Aminoglycosides are among the most important antibiotics for clinical demands for a long time. Even today, the importance of aminoglycosides is not changed at all, for example, for the treatment of HIV infection. 1>2) In view of chemical structure, aminoglycosides can be classified into two major groups. One is those having an aglycone of fully-substituted aminocyclitol which is shown or proposed to be biosynthesized from myo-inositol. Streptomycin, fortimicin, hygromycin and spectinomycin are amongthis group, and genetic as well as enzymological studies have been performed for the biosynthesis of the first two.3~5) The other group of aminoglycosides has a common aglycone of 2-deoxystreptamine (DOS), and clinically important major compounds are included in this category, Membrane was washed with 1XSSCat 65°C, and the positively hybridized bands were visualized using a DIG Luminescent Detection Kit (Boehringer Mannheim). The fragments of interest were recovered from a gel and subcloned into the multicloning site of pUC19. The resulting plasmids were transformed into E. coli JM105, OCT. 2000 which was then plated on LB agar containing SO^g/ml of ampicillin.
The colonies were transferred to HyBond-N+ membrane (Amersham Pharmacia), and screened by hybridization with the same probe, as described above, to yield pDS5. Other clones (pDSlO, ll, 12, 13 and 14) were obtained with the same methods using appropriate restriction enzymes and probes summarized in Tables 1 and  2 . The nucleotide sequence of each inserted clone was determined by construction of plasmids with digestion of pDS5, 10, ll, 12, 13 and 14 by appropriate restriction enzymes and subcloning into pUC19, and sequencing of them. constructed as follows. Plasmid pDS13 was digested with SnaB I (located on 369 bp from the starting codon ofbtrM), and the tetracycline resistance gene cassette (recovered from pBEST309 with Smal) was inserted in reverse direction to yield PHB13Tc.
Construction of Disruption Vectors
All of the plasmids and primers using in this study were summarized in Table 1 The cells of B. circulans in early log-phase was harvested by centrifugation (10,000Xg, 5 minutes), and the cells were washed with 7mM HEPES-NaOH buffer containing 272mMofsaccharose, 1 mMofMgCl2, pH 7.3 for 4 times. The collected cells were suspended in 0.5ml of the same buffer, and 1 ji\ ofplasmid solution in TE buffer was added to 100/^l of the cell suspension. The mixture was allowed to stand in an ice bath for 10 minutes, and was subjected to electroporation with EasyjecT Optima (EquiBio, UK). Subsequently, 900/il of SOC medium was added to the suspension, which was then incubated at 37°C for 1.5 hours and plated on LB agar containing 10 /ig/ml of tetracycline, 1 jiglvcA of erythromycin and 20^g/ml of chloramphenicol. Transformation wasconfirmed in all cases by recovering the plasmid from each transformant by Plasmid Midi Kit (QIAGEN). The resulting transformant was grownon Pen medium containing 1 //g/ml of tetracycline for 24 hoursX3 times, and for 72 hours. A 10^1 aliquot of culture was plated on LB plate containing 10 /ig/ml of tetracycline. The colonies were screened by using 2 types of LBagar. One contained 10/ig/ml of tetracycline only, and the other contained 10^g/ml of tetracycline, 1^ag/ml of erythromycin and 20 jig/ml of chloramphenicol. Colonies which showed a phenotype of tetracycline-resistant, erythromycin-and chloramphenicol-sensitive were picked up and cultured. Disruption of the target gene was confirmed by PCR using the genome of disruptant as a template. Primers were designed from the outside of the fragment for using each disruption vector (BC-s and BC-a for btrB disruption, CC-s and CC-a for btrC disruption, DC-s and DC-a for btrD disruption and MC-s and MC-a for btrM disruption). The program was; 94°C for 5 minutes, and modification enzymes were purchased from TaKaRa (Japan). Genomepreparations were carried out with Dr. Gentle (TaKaRa). Genetic analysis was performed with GENETYX-MAC ver. 10 (Software Development, Japan), and database search was carried out by FASTA and BLAST2on Internet. All other reagents were of the highest grade commercially available.
Accession Number
The sequence determined in the present study have been deposited in DDBJ/EMBL/GenBanknucleotide sequence databases with the accession number AB033991.
Results and Discussion
Gene-walking approach allowed us to identify 17 ORFs (2 of them were not fully-cloned) around the btrC gene (Fig. 2) . All the ORFs were located in same direction, and positioned closely to each other. Further, in the region sofar examined, neither terminator-like nor promoter-like structure was identified. Thus, the region found in the present study appeared to be a part of single operon. The deduced amino-acid sequences of these ORFs were analyzed with BLAST2 and FASTA (Table 3) , which suggested comparatively low homology with known proteins. It should be noted that these ORFs showed no significant homology with the streptomycin-biosynthetic genes. Apparently therefore, these btr genes are novel and evolutionally-different from those of myo-inositol-derived aminoglycoside biosynthetic genes. Previously described transporter of butirosin)n) were not found in the region so far analyzed in the present study.
Proposed Function of BtrM BtrM was homologous with certain glycosyltransferases (Fig. 3) . In the biosynthetic route ofbutirosin, two glycosyl transfer reactions are apparently involved (Fig. 1) binding site (Fig. 4) .26) BtrK is homologous with pyridoxal 5 ' -phosphate (PLP)-dependent decarboxylase. Recently, the structure of ornithine decarboxylase (ODC) from mouse was dissolved by X-ray crystallographic study,27) and all of the residues involved in the PLP-binding site of ODC appered to be conserved in BtrK as shown in Fig. 5 . It The AHBA-side chain is specific for butirosin among the aminoglycosides, and is a clinically important moiety. It is well-known that butirosin is refractory by the existence of AHBA to certain enzymesthat modify aminoglycosides in resistant bacteria, and AHBAis important in semisynthetic aminoglycosides active against resistant strains.29) Thus, the information for the biosynthetic mechanism of AHBA seems to be significant for the development of potential engineered biosynthesis of useful aminoglycosides.
Gene Disruption Studies
To test the dependence of butirosin biosynthesis on the above-mentioned btr genes, mutants of targeted-gene disruption were constructed by insertion of tetracycline resistance gene cassette into each gene in reverse direction.
Disruption of each gene was confirmed by PCR as described in Materials and Methods. After the tetracycline resistance gene cassette was inserted in btrB, the amplified DNA showed a fragment of a size of 1.9kb larger (3.2kb) than that of wild type (1.3kb) (Fig. 7) . The same was true'
for btrC, btrD and btrM disruption (data not shown). In addition, the DNAsequence of the PCR-amplified fragment was analyzed, and reverse-insertion of tetracycline OCT. 2000 Fig . 8 . Antibiotic producing activities of wild type and mutants ofB. circulans.
resistance gene cassette was confirmed in each disruptant. Antibiotic production was studied for each disruptants by paper disk diffusion assay, and no antibiotic producing activity was observed for all of the mutants (Fig. 8) . These facts clearly demonstrated that BtrB, BtrC, BtrD and BtrM are participated in butirosin biosynthesis. Because all of the ORFs seem to be in a single operon, the gene cluster elucidated in the present study appears to be responsible for a butirosin biosynthesis. More detailed function of each gene should be clarified in due course.
